A program that never sees the patient again after the first appointment is not running the protocol, it is selling the vials
Lake Mead Boulevard, Las Vegas, NV 89134
In the Phase 2 dose-finding trial, men and women receiving cagrilintide 4.5 mg achieved mean weight loss of 10.8% over 26 weeks
If you or a loved one has been diagnosed with gastroparesis or suffered a serious bowel injury after using Ozempic, Wegovy, Mounjaro, or another GLP-1 drug, we are here to help
If headaches persist and become more intense over time, it is highly recommended to get in touch with your healthcare provider
Either can work when: the patient is starting weight-loss medication for the first time without complicating factors